The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have issued the new SBIR contract solicitation aimed at supporting the development of innovative biomedical and behavioral research technology with the potential for commercialization.
This SBIR solicitation is a separate and independent offering from the NIH and is not connected to their year-long Omnibus SBIR/STTR Grants solicitation. The contract solicitation is much smaller, and the topics are more focused and specific to each agency’s mission. For example, topics available in this year’s solicitation range from New Methods to Detect and Assess Myocardial Fibrosis to Smartphone Application for Global Birth Defects Surveillance. Budgets are also strictly enforced, and are limited to $150,000 for Phase I and $1 million for Phase II.